Illumina (NASDAQ:ILMN) Now Covered by Stephens

Stephens started coverage on shares of Illumina (NASDAQ:ILMN – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $170.00 price objective on the life sciences company’s stock. ILMN has been the subject of a number of other research reports. Canaccord Genuity Group reiterated a […]

Leave a Reply

Your email address will not be published.

Previous post Exact Sciences (NASDAQ:EXAS) Earns Buy Rating from Analysts at Guggenheim
Next post Paychex (NASDAQ:PAYX) Upgraded at Barclays